| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 08/05/2009 | CN100522962C 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 08/05/2009 | CN100522961C Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/04/2009 | US7569575 Synthesis of locked nucleic acid derivatives |
| 08/04/2009 | US7569574 Purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 08/04/2009 | US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate |
| 08/04/2009 | US7569571 Such as N-cyclopropyl-4-methyl-3-(4-phenyl-pyrazolo[3,4-d]pyrimidin-1-yl)-benzamide; for inhibiting p38 kinase mediated diseases and disorders such as inflammatory diseases |
| 07/30/2009 | WO2009092716A1 Crystalline form of abacavir that is essentially free of solvent |
| 07/30/2009 | WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation |
| 07/30/2009 | US20090192153 Novel adenine compound |
| 07/30/2009 | CA2711059A1 Crystalline form of abacavir that is essentially free of solvent |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2081932A2 2-o'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 07/29/2009 | EP2081931A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 07/29/2009 | EP1771177A4 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 07/29/2009 | CN101492449A 6-N,N-dihydroxyethyl purine new compounds with anticancer activity and preparation method thereof |
| 07/23/2009 | WO2009091032A1 Method for producing adenine compound |
| 07/23/2009 | WO2009091031A1 Method for producing adenine compound |
| 07/23/2009 | WO2009089677A1 Theobromine production process |
| 07/23/2009 | CA2711769A1 Method for preparing adenine compound |
| 07/22/2009 | EP2080744A1 Reaction reagent for trifluoromethylation |
| 07/22/2009 | EP2079741A1 Process for the preparation of abacavir |
| 07/22/2009 | CN101490052A Therapeutic compounds and their use in cancer |
| 07/16/2009 | WO2009088518A1 A2b adenosine receptor antagonists for the treatment of cancer |
| 07/16/2009 | WO2009087066A2 Method for preparing a marked purine derivative, said derivative and uses thereof |
| 07/16/2009 | US20090181989 Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer |
| 07/16/2009 | US20090181988 Pyrazolo Pyrimidine Derivatives and Methods of Use Thereof |
| 07/16/2009 | CA2710900A1 Method for preparing a marked purine derivative, said derivative and uses thereof |
| 07/15/2009 | EP2078019A2 Purines as pkc-theta inhibitors |
| 07/15/2009 | EP2078018A1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 07/15/2009 | EP1740587A4 Selective antagonists of a-2a- adenosine receptors |
| 07/15/2009 | EP1633771B1 Macrolide-conjugates with anti-inflammatory activity |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/14/2009 | US7560550 Method for the production of OH protected[4-(2.6-diamino-9H-purine-9-yl)-1.3-dioxolane-2-yl]methanol derivatives |
| 07/14/2009 | US7560450 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 07/09/2009 | WO2009086457A2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions |
| 07/09/2009 | WO2009086077A2 A1 adenosine receptor antagonists |
| 07/09/2009 | CA2710981A1 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions |
| 07/09/2009 | CA2709772A1 A1 adenosine receptor antagonists |
| 07/08/2009 | CN101479268A 2-0'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 07/08/2009 | CN101479267A Purine derivatives as A2A agonists |
| 07/08/2009 | CN101475572A Chemical synthesis of triacetylganciclovir |
| 07/08/2009 | CN100509813C Hetereoaryl nitrile derivative |
| 07/07/2009 | US7557209 Ring closure of an amino alcohol substituted pyridine compound in the presence of a catalytic amount of acid and at least one equivalent of a trialkylorthoformate |
| 07/02/2009 | WO2009081105A2 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 07/02/2009 | WO2009079907A1 A method for preparing 4-[9-(6-aminopurine)]-2-(s)-hydroxyl-butyric acid methyl ester |
| 07/02/2009 | WO2009013545A3 Chemical compounds |
| 07/02/2009 | US20090170879 6,9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions |
| 07/01/2009 | EP2074126A2 Sulfamoyl-containing derivatives and uses thereof |
| 07/01/2009 | EP1838710B1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/01/2009 | CN101472926A Thioxanthine derivatives and their use as inhibitors of mpo |
| 07/01/2009 | CN101472925A Purine derivatives for use as adenosin A2A receptor agonists |
| 07/01/2009 | CN101469009A Methods and compositions for treating hepatitis c virus |
| 07/01/2009 | CN100506822C [*F] fluoraro-marked purine compound, its production and use |
| 06/30/2009 | US7553812 Acyclovir-peptide analogs |
| 06/30/2009 | CA2254693C Process for the preparation of aminoalcohol derivatives and their further conversion to (1r,4s)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino)-2-cyclopentenyl-1-methanol |
| 06/25/2009 | WO2009078798A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | US20090163491 selective antagonists of A2B adenosine receptors; 6-Chloro-N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-pyridin-2-yl]-N-(2-pyridin-2-yl-ethyl)-nicotinamide; for treating asthma, diarrhea, insulin resistance, and diabetic retinopathy |
| 06/25/2009 | US20090162319 Reverse transcriptase inhibitors |
| 06/25/2009 | CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/24/2009 | CN101466712A Thioxanthine derivatives and their use as inhibitors of mpo |
| 06/24/2009 | CN101463034A Preparation of triacetylganciclovir |
| 06/24/2009 | CN101463033A Method for synthesizing diprophylline |
| 06/23/2009 | US7550619 epoxidation, hydrolysis; purification of entecavir using a brominated styrene based resin (Diaion", AMBERLITE"); use for treating hepatitis B viral infections |
| 06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 06/23/2009 | US7550468 Theophylline and 3-isobutyl-1 methylxanthine based N-7 substituted derivatives displaying inhibitory activities on PDE-5 phospodiesterase |
| 06/23/2009 | US7550455 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
| 06/23/2009 | US7550442 For therapy of subject infected with a retrovirus |
| 06/23/2009 | CA2522220C Cgrp receptor antagonists |
| 06/18/2009 | WO2009074575A2 Organic compounds |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156596 Unsaturated Heterocyclic Derivatives |
| 06/18/2009 | US20090155917 Method for analyzing nucleobases on a single molecular basis |
| 06/17/2009 | EP2070940A1 Compounds with anti-inflammatory activity |
| 06/17/2009 | EP2070931A2 Process for the preparation of 2-fluoroadenine |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2070539A1 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine |
| 06/17/2009 | CN101460498A 2-thioxanthine derivatives acting as MPO-inhibitors |
| 06/17/2009 | CN101456860A Process for preparing 4-[9-(6-aminopurine)]-2(S)-hydroxybutyrate methyl ester |
| 06/17/2009 | CN101456859A Method for preparing antiviral drug valaciclovir |
| 06/17/2009 | CN100500664C Imidazole [1,2-alpha] purine derivative, method of producing same and use thereof |
| 06/16/2009 | CA2574904C Antiretroviral enantiomeric nucleotide analogs |
| 06/16/2009 | CA2311742C 6-amino-9-benzyl-8-hydroxypurine derivatives |
| 06/11/2009 | US20090149649 Aromatic hetrocyclic compound, organic light-emitting diode including organic layer comprising the aromatic hetrocyclic compound, and method of manufacturing the organic light-emitting diode |
| 06/11/2009 | US20090149482 Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment |
| 06/11/2009 | US20090149475 Thioxanthine Derivatives and Their Use as Inhibitors of MPO |
| 06/10/2009 | EP2066669A1 Adenosine derivatives as a2a receptor agonists |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | CN101454325A 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 06/10/2009 | CN100497336C Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof |
| 06/09/2009 | US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 06/09/2009 | US7544688 Hetereoaryl nitrile derivatives |
| 06/04/2009 | US20090143578 Process for Preparation of Entecavir and Novel Intermediates Thereof Via Carbon-Silicon Oxidation |
| 06/04/2009 | US20090143413 Thiazole Derivatives as CXCR3 Receptor Modulators |
| 06/04/2009 | US20090143400 Purine derivatives having immuno-modulating properties |
| 06/04/2009 | CA2699590A1 Use of purine derivatives for the manufacture of a medicament |
| 06/03/2009 | EP2065365A2 Functional monomers for molecular recognition and catalysis |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/02/2009 | US7541460 purification of entecavir using a brominated styrene based resin (Diaion", AMBERLITE"); use for treating hepatitis B viral infections |
| 06/02/2009 | US7541373 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 06/02/2009 | US7541363 (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione; excellent solubility, stability, bioavailability, dispersing property; adenosine A2 receptor antagonistic activity; treats Parkinson disease, senile dementia, depression, asthma and osteoporosis |